California Zantac Lawsuit Attorney
Proudly Serving all of California
Zantac is a common antacid medication in the US. It can be purchased over the counter and with a prescription. It treats a varied number of illnesses like heartburn, acid ingestion, ulcers, erosive esophagitis etc. But if you have ingested this drug recently, you may have been exposed to a serious risk of cancer.
California Zantac Lawsuit Attorneys Protecting You!
In September 2019, the FDA announced that it was investigating a possible risk of cancer in the common medication. It was discovered that Zantac products contain high levels of NDMA, which is likely a cancer-causing agent. And by April 2020, the FDA has requested that Zantac and all its generic forms should be withdrawn immediately. This is as a result of contamination with NDMA.
If you or a loved one has been diagnosed with cancer after being on Zantac medication, be it pancreatic cancer, stomach cancer, nasal/throat cancer, intestinal cancer or any cancer at all. You may be able to sue for damages.
Our personal injury lawyers have been actively investigating cases in which individuals took Zantac or any other form of ranitidine and then developed cancer. If you have received a cancer diagnosis after ingesting the medication, contact us for a free, no-obligation consultation.
What does Zantac do?
Zantac which is a brand name for ranitidine belongs to a group of groups called histamine-2 blockers. These blockers work by reducing the amount of acid the stomach produces. This treats conditions like Zollinger-Ellison Syndrome, a condition in which the stomach produces too much acid.
Zantac is used to treat or prevent stomach and intestinal ulcers. It is also used to treat gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the esophagus and causes heartburn.Following the relapse of the patent on ranitidine, several other drug manufacturers have produced generic forms of the medication. Although, Zantac is still the most common and popular brand. It is manufactured and sold by the pharma giant, Sanofi.
How Does Zantac Pose a Cancer Risk?
The investigation embarked on by the US Food and Drug Administration on September 13, 2019 was part of a broader inquiry into possible carcinogens. This investigation of possible cancer risks also included heart failure and blood pressure medications. As a result of finding unacceptable levels of contaminants in these medications, the FDA recommended several recalls.
An online pharmacy, Valisure, had been conducting inquiries on ranitidine as part of its own internal processes since the spring of 2019. The pharmacy discovered that there were “extremely high levels” of NDMA, a possible carcinogen, in ranitidine medications.
The carcinogen was found at alarming levels, the pills contained an excess of 3,000,000 mg per tablet. These levels are shockingly far more than the FDA’s established permissible intake of 96 mg.
The link between NDMA in Zantac and cancer has been revealed in many studies since the 1980s. If you find yourself being a victim to this medication and show symptoms of any type of cancer, or have taken it for a substantial amount of time, you might need our legal help. It is not fair that the big pharma companies have concealed the Zantac cancer link from thousands of people. We are here to help you, our firm is well equipped to represent our clients.